Alector Inc
NASDAQ:ALEC

Watchlist Manager
Alector Inc Logo
Alector Inc
NASDAQ:ALEC
Watchlist
Price: 1.46 USD -3.95% Market Closed
Market Cap: 146m USD

Relative Value

The Relative Value of one ALEC stock under the Base Case scenario is 6.37 USD. Compared to the current market price of 1.46 USD, Alector Inc is Undervalued by 77%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALEC Relative Value
Base Case
6.37 USD
Undervaluation 77%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
83
Median 3Y
4.9
Median 5Y
5.9
Industry
7.2
Forward
13.9
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-4.9
Industry
23.2
Forward
-0.7
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.7
Industry
19.3
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-2.6
Industry
22.5
vs History
88
vs Industry
59
Median 3Y
3
Median 5Y
3.4
Industry
2.7
vs History
vs Industry
86
Median 3Y
-0.5
Median 5Y
0.3
Industry
7.5
Forward
-18.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
15
vs Industry
16
Median 3Y
0.7
Median 5Y
-0.2
Industry
4.6
Forward
0.9
vs History
15
vs Industry
14
Median 3Y
0.7
Median 5Y
-0.2
Industry
4.5
Forward
1
vs History
23
vs Industry
20
Median 3Y
0.3
Median 5Y
0.1
Industry
4.9
vs History
23
vs Industry
16
Median 3Y
0.3
Median 5Y
0.1
Industry
3.7
vs History
vs Industry
72
Median 3Y
-0.8
Median 5Y
0.6
Industry
4.9

Multiples Across Competitors

ALEC Competitors Multiples
Alector Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Alector Inc
NASDAQ:ALEC
146m USD 1.7 -1.2 1.4 1.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 559 828.3 -164 257.7 -199 461.3 -197 185.2
US
Abbvie Inc
NYSE:ABBV
327.6B USD 5.7 78.9 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
155.7B USD 4.6 26.2 14.2 23.3
US
Gilead Sciences Inc
NASDAQ:GILD
134.5B USD 4.7 22.5 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 10.4 -116.5 24.7 25.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 038.5 -520.2 -566.4 -551.3
AU
CSL Ltd
ASX:CSL
115.8B AUD 4.9 27.4 16.9 21.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.6B USD 3.9 12.4 11 12.3
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60.2 -64.9 -58.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.7B USD 17.3 -150.9 -676.2 -338.8
P/S Multiple
Revenue Growth P/S to Growth
US
Alector Inc
NASDAQ:ALEC
Average P/S: 3 141 994.5
1.7
6%
0.3
FR
Pharnext SCA
OTC:PNEXF
34 559 828.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.4
10%
1
US
E
Epizyme Inc
F:EPE
2 038.5
N/A N/A
AU
CSL Ltd
ASX:CSL
4.9
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
3.9
4%
1
US
S
Seagen Inc
F:SGT
19.6
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.3
29%
0.6
P/E Multiple
Earnings Growth PEG
US
Alector Inc
NASDAQ:ALEC
Average P/E: 33.5
Negative Multiple: -1.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 257.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -116.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.4
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -150.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Alector Inc
NASDAQ:ALEC
Average EV/EBITDA: 13.3
1.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 461.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.7
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.4 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -676.2 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Alector Inc
NASDAQ:ALEC
Average EV/EBIT: 17.1
1.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 185.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.3
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -551.3 N/A N/A
AU
CSL Ltd
ASX:CSL
21.2
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.3
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -338.8 N/A N/A